PASG earnings date and last-quarter result: next report 2026-08-11, last quarter miss, P/E -0.42. Updated 2026-07-23.
Passage Bio (PASG) Research Hub
Passage Bio (PASG) trades on NASDAQ, US in the Healthcare (Biotechnology) sector. As of 2026-10-26, shares last closed at 3.359 USD (-0.33%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -0.42, market cap 0.02B. This hub links to the full technical, earnings and options research available for PASG.
Last updated 2026-10-26 · Source: end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Biotechnology) |
|---|---|
| Exchange | NASDAQ, US |
| Last close | 3.359 USD (-0.33%) |
| 52-week range | 3.32 USD – 6.3 USD |
| Trend regime | Range |
| 14-day RSI | 36.6 (Bearish) |
| Trailing P/E | -0.42 |
| Market cap | 0.02B |
| Dividend yield | 0.00% |
| Next earnings | 2026-08-11 |
Available research for PASG
Covered Call on PASG: how it works, illustrative setup around the real 3.36 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on PASG: how it works, illustrative setup around the real 3.36 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on PASG: how it works, illustrative setup around the real 3.36 USD price, max profit/loss, breakeven and when to use it. Educational.
PASG technical analysis: range, last 3.359 USD, RSI 36.6, 52w range 3.32 USD–6.3 USD, real support/resistance. Updated 2026-10-26.
More on SniperIQ
Frequently asked questions
What sector is PASG in?
Passage Bio (PASG) is classified under Healthcare (Biotechnology), listed on NASDAQ, US.
Is PASG in an uptrend or downtrend?
As of 2026-10-26, PASG is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is PASG's trailing P/E ratio?
PASG's trailing P/E is -0.42, with a market cap of 0.02B. See the earnings research page for full valuation detail.
When does PASG next report earnings?
PASG is next scheduled to report earnings on 2026-08-11.